Prophylaxis against venous thromboembolism in patients with cancer.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 25251626)

Published in N Engl J Med on September 25, 2014

Authors

Angelo Porfidia, Tiziana Morretti, Raffaele Landolfi

Articles citing this

Prophylaxis against venous thromboembolism in patients with cancer. N Engl J Med (2014) 0.77

Articles cited by this

Prophylaxis against venous thromboembolism in ambulatory patients with cancer. N Engl J Med (2014) 2.69

Articles by these authors

Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57

Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res (2013) 2.84

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood (2004) 2.64

Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol (2005) 2.50

Management of alcohol dependence in patients with liver disease. CNS Drugs (2013) 2.35

Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol (2009) 2.14

Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol (2011) 1.98

Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol (2010) 1.69

Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. J Hepatol (2013) 1.62

Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns. Dig Dis Sci (2012) 1.52

Polycythemia vera. Intern Emerg Med (2010) 1.32

The haematocrit and platelet target in polycythemia vera. Br J Haematol (2006) 1.25

Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene. Hum Genet (2001) 1.15

Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol (2010) 1.11

Polymyalgia rheumatica in 2011. Best Pract Res Clin Rheumatol (2012) 1.05

Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome. Eur Heart J (2010) 1.03

Prevention of thrombosis in polycythemia vera and essential thrombocythemia. Haematologica (2008) 1.01

The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. Cytokine Growth Factor Rev (2013) 1.01

Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm (2010) 0.94

Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels. Clin Endocrinol (Oxf) (2012) 0.92

'Doctor, treat your patient, not your monitor!' Tremor-induced ECG artefacts mimicking torsades de pointes. BMJ Case Rep (2014) 0.91

IL-1β biological treatment of familial Mediterranean fever. Clin Rev Allergy Immunol (2013) 0.89

Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms. Intern Emerg Med (2011) 0.89

Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? Int J Vasc Med (2011) 0.87

A case of variant angina in a patient under chronic treatment with sorafenib. Nat Rev Clin Oncol (2010) 0.85

Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler Thromb Vasc Biol (2013) 0.85

Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. Clin Transl Gastroenterol (2012) 0.85

Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery. Haematologica (2007) 0.84

Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. Dig Liver Dis (2012) 0.83

Distinct expression of cyclooxygenase-1 and -2 in the human thymus. Eur J Immunol (2002) 0.83

Autoimmune hemolytic anemia with gel-based immunohematology tests. Am J Clin Pathol (2013) 0.83

NSAID enteropathy: could probiotics prevent it? J Gastroenterol (2012) 0.81

IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Invest (2015) 0.81

A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease. Mol Biol Rep (2012) 0.81

TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes. Acta Diabetol (2014) 0.79

Baseline von Willebrand factor plasma levels and no-reflow phenomenon after primary percutaneous coronary intervention for ST segment elevation myocardial infarction. Int J Cardiol (2009) 0.79

Pathophysiology of thrombosis in myeloproliferative neoplasms. Haematologica (2011) 0.79

Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban. Thromb Haemost (2003) 0.79

Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina. J Am Coll Cardiol (2003) 0.78

Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. Int J Cardiol (2005) 0.78

MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation. Am J Hematol (2003) 0.77

In vivo and in vitro effects of different anaesthetics on platelet function. Br J Haematol (2004) 0.77

Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype. Blood (2002) 0.76

Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise. Thromb Res (2007) 0.76

Influence of left ventricular hypertrophy on microvascular dysfunction and left ventricular remodelling after acute myocardial infarction. Eur J Echocardiogr (2010) 0.76

'Monolateral' superior vena cava syndrome: right internal jugular vein occlusion. BMJ Case Rep (2014) 0.75

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Lancet (2002) 0.75

Patent foramen ovale and hypercoagulable state in the pathogenesis of acute thrombotic myocardial infarction. BMJ Case Rep (2009) 0.75

Cardiovascular Involvement in Erdheim-Chester Disease: A Case Report and Review of the Literature. Medicine (Baltimore) (2015) 0.75

Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm. World J Gastroenterol (2011) 0.75

V1-V2-V3-V4 T wave inversion: left or right ventricle? BMJ Case Rep (2013) 0.75

Leukocyte Activation in Obese Patients: Effect of Bariatric Surgery. Medicine (Baltimore) (2015) 0.75

Alcoholic cardiomyopathy. BMJ Case Rep (2013) 0.75

Brugada electrocardiographic findings in an 80-year-old man. BMJ Case Rep (2013) 0.75

Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects. Thromb Haemost (2002) 0.75

Regression of endothelial dysfunction in patients with endometriosis after surgical treatment: a 2-year follow-up study. Hum Reprod (2014) 0.75

The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiency. Br J Haematol (2004) 0.75

Two naturally occurring mutations on FVII gene (S363I-W364C) altering intrinsic catalytic activity. Thromb Haemost (2002) 0.75

An 85-year-old man with acute-onset of confusion and dyspnea after a fall: a diagnostic challenge. Intern Emerg Med (2014) 0.75

Autoimmune hemolytic anemia with gel-based immunohematology tests: neural network analysis. Immunol Res (2014) 0.75

Evaluating the risk of venous thromboembolism in medical patients: which criteria? Am J Emerg Med (2012) 0.75

[Characteristics and clinical use of rivaroxaban for the treatment of atrial fibrillation and venous thromboembolism]. G Ital Cardiol (Rome) (2014) 0.75

Corrigendum: Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients. Sci Rep (2016) 0.75

Prothrombotic response to coronary angioplasty in patients with unstable angina and raised C-reactive protein. J Thromb Thrombolysis (2002) 0.75

Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. Ann Clin Lab Sci (2010) 0.75

Bilateral axillary vein thrombosis in a young patient with lupus anticoagulant and clavicular bone spurs. Thromb Haemost (2007) 0.75

Haemoglobin levels in autoimmune haemolytic anaemias at diagnosis: relationship with immunoproteins on red blood cells. Immunol Res (2014) 0.75

Retrievable filter as an unusual cause of abdominal and lower back pain: a report of an exceptional case. Thromb Haemost (2008) 0.75

Perception of Thromboembolism Risk: Differences between the Departments of Internal Medicine and Emergency Medicine. Keio J Med (2016) 0.75